APA

Ivachtchenko A. V., Kovalenko S. M., Kravchenko D. V., Mitkin O. D., Ivanov V. V. & Langer T. (2020). Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2. : Acta crystallographica. Section E, Crystallographic communications.

Chicago

Ivachtchenko Alexandre V, Kovalenko Sergiy M, Kravchenko Dmitry V, Mitkin Oleg D, Ivanov Vladimir V and Langer Thierry. 2020. Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2. : Acta crystallographica. Section E, Crystallographic communications.

Harvard

Ivachtchenko A. V., Kovalenko S. M., Kravchenko D. V., Mitkin O. D., Ivanov V. V. and Langer T. (2020). Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2. : Acta crystallographica. Section E, Crystallographic communications.

MLA

Ivachtchenko Alexandre V, Kovalenko Sergiy M, Kravchenko Dmitry V, Mitkin Oleg D, Ivanov Vladimir V and Langer Thierry. Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2. : Acta crystallographica. Section E, Crystallographic communications. 2020.